NCT00218426View on ClinicalTrials.gov

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

November 4, 2010

Conditions
Heroin DependenceOpioid-Related Disorders
Interventions
DRUG

naltrexone implant

naltrexone implant is 1000 mg naltrexone

DRUG

oral naltrexone

oral naltrexone 50 mg/day

DRUG

oral placebo naltrexone

oral placebo naltrexone resembles active medication

DRUG

placebo implant

placebo implant resembles active medication

Trial Locations (2)

197022

Pavlov Medical University, Saint Petersburg

19104 6178

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

St. Petersburg State Pavlov Medical University

OTHER

lead

University of Pennsylvania

OTHER

NCT00218426 - Addiction Treatment in Russia: Oral vs. Naltrexone Implant | Biotech Hunter | Biotech Hunter